Liver carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Besides PYCR1, we found that additional proline biosynthetic enzymes, such as ALDH18A1, were upregulated in HCC models and also regulated HCC cell proliferation.
|
31726117 |
2020 |
HHH syndrome
|
0.010 |
Biomarker
|
disease |
BEFREE |
Hereditary Spastic Paraplegia Is a Common Phenotypic Finding in ARG1 Deficiency, P5CS Deficiency and HHH Syndrome: Three Inborn Errors of Metabolism Caused by Alteration of an Interconnected Pathway of Glutamate and Urea Cycle Metabolism.
|
30853934 |
2019 |
Cerebellar Ataxia
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
SPG9B might involve a complicated HSP including cerebellar ataxia and cognitive impairment.
|
29915212 |
2018 |
Impaired cognition
|
0.010 |
Biomarker
|
disease |
BEFREE |
SPG9B might involve a complicated HSP including cerebellar ataxia and cognitive impairment.
|
29915212 |
2018 |
Complicated hereditary spastic paraplegia
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Novel mutations in the ALDH18A1 gene in complicated hereditary spastic paraplegia with cerebellar ataxia and cognitive impairment.
|
29915212 |
2018 |
Spastic paraplegia type 5A, recessive
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We present a 19-year old male patient with autosomal recessive spastic paraplegia and compound heterozygosity for two ALDH18A1 mutations, one in each of the P5CS domains.
|
29754261 |
2018 |
Luminal A Breast Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
High ALDH18A1 and high GLS protein expression was observed in the oestrogen receptor (ER)+/human epidermal growth factor receptor (HER2)- high proliferation class (Luminal B) compared with ER+/HER2- low proliferation class (Luminal A) (P=0.030 and P=0.022 respectively), however this was not observed with mRNA.
|
29169183 |
2018 |
Luminal B Breast Carcinoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
High ALDH18A1 and high GLS protein expression was observed in the oestrogen receptor (ER)+/human epidermal growth factor receptor (HER2)- high proliferation class (Luminal B) compared with ER+/HER2- low proliferation class (Luminal A) (P=0.030 and P=0.022 respectively), however this was not observed with mRNA.
|
29169183 |
2018 |
Abnormality of the skeletal system
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Autosomal dominant (AD) complex HSP with skeletal abnormalities are consistently seen only in SPG9 (spastic gait type 9).
|
30029526 |
2018 |
Fatty Liver Disease
|
0.010 |
Biomarker
|
disease |
BEFREE |
Some of the novel aberrant gene expression, mutations and core oncogenic pathways identified in cholesterol-associated NASH-HCCs in mice were confirmed in human NASH-HCCs, which included metabolism-related genes (ALDH18A1, CAD, CHKA, POLD4, PSPH and SQLE) and recurrently mutated genes (RYR1, MTOR, SDK1, CACNA1H and RYR2).
|
30367044 |
2018 |
Neoplasm Metastasis
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
GSAS/N5 cells that had been injected into the nude mouse tongue and harvested from metastasized lungs multiplied angiopoietin-like 4 (angptl4) expression with enhanced migration activity, which indicated a possible involvement of angptl4 in lung metastasis of the cells.
|
27511626 |
2016 |
Secondary malignant neoplasm of lung
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
GSAS/N5 cells that had been injected into the nude mouse tongue and harvested from metastasized lungs multiplied angiopoietin-like 4 (angptl4) expression with enhanced migration activity, which indicated a possible involvement of angptl4 in lung metastasis of the cells.
|
27511626 |
2016 |
melanoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Thus, targeting ALDH18A1 in melanoma can be used to disrupt proline biosynthesis to limit cell metabolism thereby increasing the cellular doubling time mediated through the GCN2 pathway.
|
26082174 |
2015 |
Neoplasms
|
0.010 |
Biomarker
|
group |
BEFREE |
Inhibition of ALDH18A1, the gene encoding pyrroline-5-carboxylate synthase (P5CS), significantly decreased cultured melanoma cell viability and tumor growth.
|
26082174 |
2015 |
Progeria
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
In conclusion, the clinical phenotype caused by ALDH18A1 mutations is diverse, with variable degree of progeria in children, but always in association with neurologic disease.
|
24767728 |
2014 |
Retinal Diseases
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Cutis laxa, fat pads and retinopathy due to ALDH18A1 mutation and review of the literature.
|
24767728 |
2014 |
Retinitis Pigmentosa
|
0.010 |
Biomarker
|
disease |
BEFREE |
Furthermore, abnormal fat distribution, retinal abnormalities, undescended testis, and retinitis pigmentosa have never been described in ALDH18A1.
|
24767728 |
2014 |
Agenesis of corpus callosum
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Corpus callosum dysgenesis was associated with PYCR1 and ALDH18A1 mutations.
|
23963297 |
2014 |
Dysgenesis of corpus callosum
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Corpus callosum dysgenesis was associated with PYCR1 and ALDH18A1 mutations.
|
23963297 |
2014 |
Congenital cutis laxa
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Severe congenital cutis laxa with cardiovascular manifestations due to homozygous deletions in ALDH18A1.
|
24913064 |
2014 |
Cutis laxa, autosomal recessive
|
0.010 |
Biomarker
|
disease |
BEFREE |
ALDH18A1-related ARCL is the most severe form within this disease spectrum.
|
24913064 |
2014 |
Dementia due to Alzheimer's disease (disorder)
|
0.010 |
Biomarker
|
disease |
BEFREE |
Association of variants within APOE, SORL1, RUNX1, BACE1 and ALDH18A1 with dementia in Alzheimer's disease in subjects with Down syndrome.
|
20946940 |
2011 |
Metabolic Diseases
|
0.010 |
AlteredExpression
|
group |
BEFREE |
The deficiency of P5CS activity in humans is associated with a rare, inherited metabolic disease.
|
20091669 |
2010 |
Flatfoot
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Recently, we reported a newly recognised inborn error due to deficiency of P5CS in two sibs, one presenting at birth with hypotonia, dysmorphic signs, pes planus and clonic seizures.
|
15517380 |
2005 |
Clonic Seizures
|
0.010 |
Biomarker
|
disease |
BEFREE |
Recently, we reported a newly recognised inborn error due to deficiency of P5CS in two sibs, one presenting at birth with hypotonia, dysmorphic signs, pes planus and clonic seizures.
|
15517380 |
2005 |